scispace - formally typeset
B

Bhari Mallanna Nagaraja

Researcher at Jain University

Publications -  60
Citations -  2566

Bhari Mallanna Nagaraja is an academic researcher from Jain University. The author has contributed to research in topics: Catalysis & Dehydrogenation. The author has an hindex of 22, co-authored 52 publications receiving 1958 citations. Previous affiliations of Bhari Mallanna Nagaraja include Korea Institute of Science and Technology & University of Limerick.

Papers
More filters
Journal ArticleDOI

Vapor phase selective hydrogenation of furfural to furfuryl alcohol over Cu–MgO coprecipitated catalysts

TL;DR: In this article, the catalytic vapor phase hydrogenation of furfural (FAL) to furfuryl alcohol (FOL) at atmospheric pressure, the gas hourly space velocity (GHSV) has been maintained at 0.5.
Journal ArticleDOI

Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry.

TL;DR: This work systematically gives a comprehensive review in current developments of benzimidazole‐based compounds in the whole range of medicinal chemistry as anticancer, antibacterial, antifungal, anti‐inflammatory, analgesic agents, anti-HIV, antioxidant, anticonvulsant, antitubercular, antidiabetic, antileishmanial, antihistaminic, antimalarial agents, and other medicinal agents.
Journal ArticleDOI

A highly efficient Cu/MgO catalyst for vapour phase hydrogenation of furfural to furfuryl alcohol

TL;DR: In this article, a highly efficient Cu/MgO catalyst for the vapour phase hydrogenation of furfural at atmospheric pressure has been prepared by coprecipitation method, which is attributed to the more surface Cu sites as evidenced from N 2 O pulse chemisorption technique and the defective sites at Cu and MgO interfacial region.
Journal ArticleDOI

An overview of benzo[b]thiophene-based medicinal chemistry

TL;DR: The present review is endeavoring to highlight the progress in the various pharmacological activities of benzo[b]thiophene derivatives to help for rational designs of more active and less toxic benzothiophene-based medicinal drugs, as well as more effective diagnostic agents and pathologic probes.
Journal ArticleDOI

Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.

TL;DR: This review collated published reports on coumarin derivatives to shed light on the insights on different types of methods reported for their preparations, characterizations and anti-TB applications, so that its full therapeutic potential class of compounds can be utilized for the treatment of tuberculosis.